SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile (C. diff) for up to 2 months with no major safety signals, according to a ...

Canadian researchers conducted a clinical trial at three academic centers in Alberta, Canada. The trial included 116 adult patients with recurrent C. diff, enrolled between October 2014 and September ...

Please provide your email address to receive an email when new articles are posted on . Ninety-five percent of patients achieved treatment success at 8 weeks after administration of Rebyota via ...

When comparing four treatments for recurrent Clostridium difficile, researchers found fecal microbiota transplant colonoscopies may be the most cost effective, according to a study in Clinical ...

The digestive disorder known as Clostridium difficile, or C. diff, is a potentially life-threatening intestinal infection, but there is an option out there that's fast and has about a 90-percent ...

C. difficile bacterium Oral capsule FMT and colonoscopy delivery showed similar patient outcomes, low rate differences, and high success rates. Oral capsule fecal microbiota transplantation (FMT) was ...

SAN DIEGO — A new analysis of the cost effectiveness of various strategies to combat recurring Clostridium difficile infections (CDIs) shows that fecal microbial transplantation delivered by ...